Canada's Brain Health PRO Trial Tests Online Dementia Prevention at Scale
A completed Canadian platform trial enrolls 354 at-risk adults in a multidomain online brain health program targeting dementia prevention.
Summary
The CAN-THUMBS UP trial tested Brain Health PRO, an interactive online program designed to help adults at risk of dementia improve their knowledge and lifestyle habits linked to cognitive decline. Conducted across Canada and sponsored by Baycrest, the study enrolled 354 community-dwelling individuals who showed signs of subjective or mild cognitive impairment. The program aimed to boost dementia literacy, encourage healthier behaviors, and serve as a foundation for an open platform trial testing multiple interventions simultaneously. Completed in April 2024, results from this innovative trial could inform scalable, accessible strategies for dementia prevention that go beyond clinic walls and reach the broader public through digital tools.
Detailed Summary
Dementia prevention has become one of the most urgent challenges in global health. With no disease-modifying drugs widely available, lifestyle-based multidomain interventions represent one of the most promising avenues for reducing risk. Yet most such programs are resource-intensive and difficult to scale. The CAN-THUMBS UP trial set out to address this gap using a digital-first approach.
The study evaluated Brain Health PRO, an engaging online educational program designed to influence dementia literacy and modifiable lifestyle risk factors such as physical activity, diet, sleep, and cognitive engagement. The platform was tested within a broader Canadian Therapeutic Platform Trial framework, which allows multiple interventions to be evaluated simultaneously within a shared infrastructure — a more efficient model than traditional single-intervention trials.
A cohort of 354 community-dwelling adults at elevated dementia risk, including those with subjective cognitive impairment or mild cognitive impairment, were enrolled starting in April 2022. The trial was completed in April 2024. Participants engaged with the online program, which was designed to be both interactive and compelling enough to sustain long-term engagement — a known challenge in digital health interventions.
The platform trial model used here is particularly noteworthy. By establishing a retained cohort and a flexible infrastructure, CAN-THUMBS UP can efficiently test additional interventions in the future without starting from scratch, dramatically accelerating the pace of dementia prevention research in Canada and potentially worldwide.
However, several caveats apply. The abstract does not report outcome data, so the effectiveness of Brain Health PRO on cognitive or lifestyle outcomes remains unpublished at this time. The relatively small enrollment of 354 participants may also limit generalizability. Additionally, self-selected online participants may not represent populations with the greatest dementia risk or lowest health literacy.
Key Findings
- 354 at-risk Canadian adults enrolled in a completed digital multidomain dementia prevention trial.
- Brain Health PRO targets modifiable risk factors including diet, exercise, sleep, and cognitive engagement.
- Platform trial design enables future add-on interventions without launching entirely new studies.
- Program designed to scale nationally, reaching beyond clinical settings to the broader Canadian public.
- Trial includes those with subjective and mild cognitive impairment, catching risk early in the spectrum.
Methodology
CAN-THUMBS UP is a platform clinical trial with no assigned phase, enrolling 354 community-dwelling adults at dementia risk. Participants received the Brain Health PRO online educational intervention, with the infrastructure designed to support future add-on intervention arms. The trial ran from April 2022 to April 2024 under Baycrest sponsorship.
Study Limitations
This summary is based on the abstract only, as the full study results are not publicly available; outcome data on dementia literacy, lifestyle change, or cognitive performance have not been reported. The sample of 354 may be underpowered for detecting modest cognitive effects. Self-selection into an online program may limit generalizability to lower-health-literacy or older populations with greater dementia risk.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.